PlumX Metrics
Embed PlumX Metrics

Low-grade inflammation and serotonin 4 receptor binding in the healthy and the depressed brain

Neuroscience Applied, ISSN: 2772-4085, Vol: 3, Page: 104078
2024
  • 2
    Citations
  • 0
    Usage
  • 9
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Inflammatory status affects healthy brain function and also low-grade inflammation putatively contributes to the pathophysiology of Major Depressive Disorder (MDD). This psychoneuro-immunological interplay is complex, bidirectional, and not fully understood. Also, it is not clear to what extent depressive states induce inflammation and/or if increased inflammation leads to depressive symptoms by affecting brain biology including serotonin signaling. The serotonin 4 receptor (5-HT 4 R) is an interesting new antidepressant target; direct stimulation has antidepressant-like, and pro-cognitive effects, and may also index serotonin tone at least in the adult healthy brain. Here, we investigate whether a peripheral marker of low-grade inflammation (hsCRP) is associated with 5-HT 4 R brain binding in both a healthy and in an unmedicated MDD group. 5-HT 4 R PET imaging data and hsCRP measures from 112 healthy and 79 unmedicated MDD individuals were available from the Cimbi database. We evaluated the associations between hsCRP level and 5-HT 4 R binding in three regions of interest (neocortex, hippocampus, and neostriatum) using multiple linear regression models adjusted for relevant covariates. We did not observe a statistically significant association between hsCRP and 5-HT 4 R binding. This applied to both the healthy and the MDD group. Our findings do not support a coupling between low-grade inflammation and brain 5-HT 4 R availability, which suggests that the serotonergic system is not sensitive to low-grade inflammation captured by hsCRP, neither in healthy nor in depressed states. Future studies are needed to test if the brain serotonin system is coupled to other inflammatory markers, for instance in conditions with high-grade and/or prolonged immunoactivation.

Bibliographic Details

Mette Clausen; Søren Vinther Larsen; Emma Sofie Hogsted; Arafat Nasser; Claus Svarer; Gitte Moos Knudsen; Vibe Gedso Frokjaer

Elsevier BV

Neuroscience

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know